Myriad Uranium Completes Sale of Red Basin Uranium Project to VC-Backed Subatomic, Retains 10% Free Carried Interest and Enters into Strategic Alliance

Myriad just turned a small uranium bet into real cash, not just promises.

What the company is saying

Myriad Uranium Corp. is positioning itself as a nimble uranium developer that can generate real value through smart project transactions and strategic partnerships. The company’s core narrative is that it acquired the Red Basin Uranium Project for C$525,000 just 15 months ago and has now sold it for US$2,500,000 (C$3.43 million), delivering an over 6x cash-on-cash return—an outcome they frame as both rare and highly accretive for shareholders. Management emphasizes the non-dilutive nature of this cash inflow, highlighting that the treasury receives a C$3.4 million boost without issuing new shares or taking on debt. They also stress the retained 10% free carried interest in Red Basin, suggesting future upside if the project advances under new ownership. The announcement is careful to spotlight the strategic alliance with Subatomic, which is described as a milestone for American uranium production, but provides no concrete details or financial terms for this partnership. The company’s tone is confident and factual, with President and CEO Thomas Lamb quoted directly, but it avoids overhyping forward-looking elements—such as the pending Copper Mountain merger and the potential US stock exchange listing—by acknowledging these are in progress rather than completed. Notably, Subatomic’s CEO Timothy Chilleri is mentioned, but there is no evidence of direct institutional investment from 8VC or Overmatch Ventures into Myriad itself; their involvement is limited to backing Subatomic. The messaging fits a broader investor relations strategy of demonstrating capital discipline, deal-making ability, and US market ambitions, while keeping the focus on tangible, realised outcomes. Compared to typical junior mining communications, the language is less promotional and more grounded in completed transactions, though it still leans on the promise of future catalysts.

What the data suggests

The disclosed numbers show that Myriad acquired the Red Basin Uranium Project for C$525,000 and sold it for US$2,500,000 (C$3.43 million), resulting in an over 6x cash-on-cash return in just over a year. This is a rare, realised win in the junior uranium sector, where most value is usually tied up in long-dated exploration or development. The immediate financial impact is a non-dilutive C$3.4 million boost to the treasury, with no evidence of new debt or share dilution. The company retains a 10% free carried interest in Red Basin, but the value and timing of any future proceeds from this are entirely speculative and not quantified. There is no updated balance sheet, income statement, or per-share metric provided, so it is not possible to assess the broader financial trajectory or compare this event to prior periods. The announcement is transparent about the Red Basin transaction but omits key financial details for the Copper Mountain project and the strategic alliance with Subatomic. An independent analyst would conclude that the Red Basin sale is a clear, positive financial event, but that the company’s overall financial health and future value drivers remain opaque due to limited disclosure on other assets and operations.

Analysis

The announcement's tone is positive but proportionate to the measurable progress disclosed. The core of the release is the completed sale of the Red Basin Uranium Project for US$2,500,000, with a clear over 6x cash-on-cash return in about 15 months, and a non-dilutive C$3.4 million boost to the treasury. These are realised, not aspirational, outcomes, and are supported by explicit numerical data. While there are forward-looking statements about a strategic alliance, a pending merger, and a potential US listing, these are secondary to the main, completed transaction. No large capital outlay is disclosed without immediate benefit; instead, the company is realising cash inflow. The language is factual and does not inflate the realised financial achievement. The gap between narrative and evidence is minimal, with most claims directly supported by disclosed numbers.

Risk flags

• ●The majority of future value claims—such as the 10% retained interest in Red Basin, the strategic alliance with Subatomic, and the US stock exchange listing—are forward-looking and lack binding timelines or quantifiable milestones. This matters because investors cannot reliably model or value these potential upsides.
• ●There is no disclosure of updated resource estimates, technical reports, or production forecasts for any of Myriad’s projects. This operational opacity makes it difficult for investors to assess the underlying asset quality or future cash flow potential.
• ●The financial disclosures are limited to the Red Basin transaction; there is no updated balance sheet, income statement, or per-share data. This lack of comprehensive financial reporting prevents investors from understanding the company’s overall liquidity, burn rate, or capital needs.
• ●The strategic alliance with Subatomic is described in aspirational terms, with no details on structure, funding, or specific projects. Without concrete terms, this partnership could amount to little more than a press release headline.
• ●The Copper Mountain project is referenced as a key asset, but there is no disclosure of current exploration results, development plans, or capital requirements. The pending acquisition of the remaining 25% interest is not yet closed, introducing execution risk.
• ●The company is pursuing a US stock exchange listing, but there is no timeline, no evidence of regulatory progress, and no guarantee of approval. Listing on NYSE or NASDAQ is a complex, uncertain process that often takes longer and costs more than anticipated.
• ●Geographic focus is split between New Mexico (Red Basin), Wyoming (Copper Mountain), and broader US uranium opportunities, but there is no discussion of jurisdictional risks, permitting challenges, or local opposition—factors that can materially impact project timelines and costs.
• ●While Subatomic’s parent company is backed by 8VC and Overmatch Ventures, there is no evidence that these institutional investors have any direct exposure to Myriad. Their involvement is a positive signal for Subatomic’s credibility, but does not guarantee future deals, funding, or operational success for Myriad.

Bottom line

For investors, this announcement is a rare example of a junior uranium company turning a modest project acquisition into a substantial, realised cash gain in a short period. The Red Basin sale is fully completed, the cash is in the treasury, and the over 6x return is not just theoretical—it is banked. However, the company’s future value drivers, including the 10% retained interest in Red Basin, the strategic alliance with Subatomic, the Copper Mountain project, and the US stock exchange listing, are all forward-looking and lack the detail or certainty needed for robust valuation. The narrative is credible as far as the Red Basin transaction goes, but investors should be cautious about extrapolating this success to other projects or assuming that future catalysts will materialise on similar terms. The mention of institutional backers like 8VC and Overmatch Ventures is relevant only to Subatomic, not Myriad, and does not guarantee any direct benefit to Myriad shareholders. To change this assessment, the company would need to provide detailed, time-bound updates on the Copper Mountain acquisition, resource estimates, operational plans, and concrete steps toward a US listing. Key metrics to watch in the next reporting period include cash balance, progress on the Copper Mountain merger, and any binding agreements arising from the Subatomic alliance. This announcement is a strong signal to monitor—especially for evidence of repeatable value creation—but not yet a reason to buy or materially reweight a portfolio. The single most important takeaway is that Myriad has demonstrated it can execute and monetise a project, but the path to future value remains unproven and requires much more disclosure.

Announcement summary

Myriad Uranium Corp. (CSE: M, OTCQB: MYRUF) has completed the sale of its Red Basin Uranium Project in New Mexico, USA, to Subatomic Red Basin, LLC for US$2,500,000. Myriad retains a 10% free carried interest in the project and has formed a strategic alliance with Subatomic to explore further uranium opportunities beyond Red Basin. The sale represents an over 6x cash-on-cash return for Myriad, as the project was acquired approximately 15 months ago for C$525,000 and sold for C$3.43 million, excluding the retained interest. Myriad is also advancing its Copper Mountain Uranium Project in Wyoming and is in the process of acquiring the remaining 25% interest via a merger with Rush Rare Metals. The company is pursuing a listing on a major US stock exchange, with NYSE and NASDAQ as options. Subatomic's parent company is backed by 8VC and Overmatch Ventures, and both parties see the partnership as a milestone in American uranium production. Further details on Phase II drilling at Copper Mountain and the US listing are expected soon.

Disagree with this article?